» Articles » PMID: 20808875

Identification of a Cardiac Specific Protein Transduction Domain by in Vivo Biopanning Using a M13 Phage Peptide Display Library in Mice

Overview
Journal PLoS One
Date 2010 Sep 3
PMID 20808875
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A peptide able to transduce cardiac tissue specifically, delivering cargoes to the heart, would be of significant therapeutic potential for delivery of small molecules, proteins and nucleic acids. In order to identify peptide(s) able to transduce heart tissue, biopanning was performed in cell culture and in vivo with a M13 phage peptide display library.

Methods And Results: A cardiomyoblast cell line, H9C2, was incubated with a M13 phage 12 amino acid peptide display library. Internalized phage was recovered, amplified and then subjected to a total of three rounds of in vivo biopanning where infectious phage was isolated from cardiac tissue following intravenous injection. After the third round, 60% of sequenced plaques carried the peptide sequence APWHLSSQYSRT, termed cardiac targeting peptide (CTP). We demonstrate that CTP was able to transduce cardiomyocytes functionally in culture in a concentration and cell-type dependent manner. Mice injected with CTP showed significant transduction of heart tissue with minimal uptake by lung and kidney capillaries, and no uptake in liver, skeletal muscle, spleen or brain. The level of heart transduction by CTP also was greater than with a cationic transduction domain.

Conclusions: Biopanning using a peptide phage display library identified a peptide able to transduce heart tissue in vivo efficiently and specifically. CTP could be used to deliver therapeutic peptides, proteins and nucleic acid specifically to the heart.

Citing Articles

Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines.

Xiao W, Jiang W, Chen Z, Huang Y, Mao J, Zheng W Signal Transduct Target Ther. 2025; 10(1):74.

PMID: 40038239 PMC: 11880366. DOI: 10.1038/s41392-024-02107-5.


Engineering extracellular vesicles for targeted therapeutics in cardiovascular disease.

Fu E, Pan K, Li Z Front Cardiovasc Med. 2025; 11:1503830.

PMID: 39749310 PMC: 11693616. DOI: 10.3389/fcvm.2024.1503830.


Extracellular vesicle therapeutics for cardiac repair.

Hu Y, Zhang W, Ali S, Takeda K, Vahl T, Zhu D J Mol Cell Cardiol. 2024; 199:12-32.

PMID: 39603560 PMC: 11788051. DOI: 10.1016/j.yjmcc.2024.11.005.


Beyond Transduction: Anti-Inflammatory Effects of Cell Penetrating Peptides.

Lopuszynski J, Wang J, Zahid M Molecules. 2024; 29(17).

PMID: 39274936 PMC: 11397606. DOI: 10.3390/molecules29174088.


Identification of In Vivo Internalizing Cardiac-Specific RNA Aptamers.

Narayan C, Lin L, Barros M, Gilbert T, Brown C, Reddin D bioRxiv. 2024; .

PMID: 39185150 PMC: 11343129. DOI: 10.1101/2024.08.13.607054.


References
1.
Pasqualini R, Ruoslahti E . Organ targeting in vivo using phage display peptide libraries. Nature. 1996; 380(6572):364-6. DOI: 10.1038/380364a0. View

2.
Hyun S, Lee E, Park J, Yu J . Tentacle type peptides as artificial lectins against sulfated Lewis X and A. Bioorg Med Chem Lett. 2008; 18(14):4011-4. DOI: 10.1016/j.bmcl.2008.06.003. View

3.
Molenaar T, Michon I, de Haas S, Van Berkel T, Kuiper J, Biessen E . Uptake and processing of modified bacteriophage M13 in mice: implications for phage display. Virology. 2002; 293(1):182-91. DOI: 10.1006/viro.2001.1254. View

4.
Segvich S, Smith H, Kohn D . The adsorption of preferential binding peptides to apatite-based materials. Biomaterials. 2008; 30(7):1287-98. PMC: 2744811. DOI: 10.1016/j.biomaterials.2008.11.008. View

5.
Wiviott S, Morrow D, Frederick P, Giugliano R, Gibson C, McCabe C . Performance of the thrombolysis in myocardial infarction risk index in the National Registry of Myocardial Infarction-3 and -4: a simple index that predicts mortality in ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2004; 44(4):783-9. DOI: 10.1016/j.jacc.2004.05.045. View